Ck7+ ck20+ tumors

The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody, Diagnostic Pathology

CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma - Masashi Miyaoka, Kazuhito Hatanaka, Masayuki Iwazaki, Naoya

Cancers, Free Full-Text

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma

Metastatic carcinoma of unknown primary (Chapter 12) - Modern Immunohistochemistry

Carcinoma Micropapilar Rectal Puro con Coexpresión de CK7 y CK20 y Pérdida de Reactividad CDX2

Eurocytology

Identification of the primary tumor site by immunohistochemistry and gene analysis.

A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens

Identical cytokeratin expression pattern CK7+/CK20− in esophageal and cardiac cancer: etiopathological and clinical implications

PDF] CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.